NASAL ADMINISTRATION OF AN ALTERED PEPTIDE LIGAND OF INSULIN PEPTIDE B:9-23 WITH CHOLERA TOXIN SUPPRESSES THE EXPRESSION OF INSULIN AUTOANTIBODIES AND PREVENTS DIABETES IN THE NOD MOUSE
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-10-01
著者
-
KAWASAKI E.
Japan Diabetes Society Committee on Fulminant Type 1 Diabetes Mellitus Research
-
EISENBARTH G.
Barbara Davis Center for Childhood Diabetes, University of Colorado
-
Eisenbarth G.
Barbara Davis Center For Childhood Diabetes Uchsc
-
Eisenbarth G.
Barbara Davis Center For Childhood Diabetes University Of Colorado
-
Kobayashi M.
Dept of Physic Fac. Of Sci. Niigata Univ.
-
Miao D.
Barbara Davis Center For Childhood Diabetes Uchsc
-
Abiru N.
1st Dept Of Int Med Nagasaki Univ.
-
KAWASAKI E.
Dept of Metab/Diab and Clinical Nutr, Nagasaki Univ.
-
LIU E.
Barbara Davis Center for Childhood Diabetes, UCHSC
-
FUKUSHIMA K.
1st Dept of Int Med, Nagasaki Univ.
-
YAMASAKI H.
1st Dept of Int Med, Nagasaki Univ.
-
EGUCHI K.
1st Dept of Int Med, Nagasaki Univ.
-
Eguchi K.
1st Dept Of Int Med Nagasaki Univ.
関連論文
- CLINICAL AND IMMUNOGENETIC CHARACTERISTICS OF FULMINANT TYPE 1 DIABETES ASSOCIATED WITH PREGNANCY
- INSULIN REACTIVE T CELLS IN EAD (EXPERIMENTAL AUTOIMMUNE DIABETES) MODEL
- THE EFFECT OF SHAPE OF OXYGEN EQUILIBRIUM CURVE OnN THE OXYGEN TRANSPORT ABILITY OF HUMAN HEMOGLOBIN(Physiology)(Proceedings of the Seventieth Annual Meeting of the Zoological Society of Japan)
- ELIMINATION OF CTL EPITOPE FROM INSULIN PEPTIDE B:9-23 PROVIDES NASAL-INDUCED SUPPRESSION OF INSULITIS AND DIABETES IN THE NOD MOUSE
- NASAL ADMINISTRATION OF AN ALTERED PEPTIDE LIGAND OF INSULIN PEPTIDE B:9-23 WITH CHOLERA TOXIN SUPPRESSES THE EXPRESSION OF INSULIN AUTOANTIBODIES AND PREVENTS DIABETES IN THE NOD MOUSE